Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis

Table 1

Research summaries comparing the effects of cannabinoids and placebo.

Study ID	Study method	Human subjects	Interventional group	Control group	Follow-up (d)	Outcomes
Brisbois 2011	parallel-group RCTs	advanced cancer patients	THC (2.5 mg, n = 24)	Placebo (n = 22)	19	Appetite, AEs, QOL
Johnson 2010	parallel-group RCTs	advanced cancer patients	THC:CBD extract (2.7 mg THC and 2.5 mg CBD, n = 60), THC extract (2.7 mg THC, n = 58)	Placebo (n = 59)	14	Appetite, AEs, QOL
Strasser 2006	parallel-group RCTs	advanced cancer patients	CE (standardized for 2.5 mg THC and 1 mg cannabidiol, n = 95) or THC (2.5 mg, n = 100)	Placebo (n = 48)	42	Body Weight, Appetite, AEs, QOL